Proteomics-Derived Cerebrospinal Fluid Markers of Autopsy-Confirmed Alzheimer’s Disease

Biomarkers - United Kingdom
doi 10.3109/13547500903108423
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer’s Disease

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2016English

Neuropsychiatric Correlates of Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease

Dementia and Geriatric Cognitive Disorders
PsychiatryGerontologyGeriatricsMental HealthCognitive Neuroscience
2008English

Cerebrospinal Fluid Soluble TREM2 in Aging and Alzheimer’s Disease

Alzheimer's Research and Therapy
NeurologyCognitive Neuroscience
2016English

Cerebrospinal Fluid Concentrations of Extracellular Matrix Proteins in Alzheimer’s Disease

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2019English

Cerebrospinal Fluid PKR Level Predicts Cognitive Decline in Alzheimer’s Disease

PLoS ONE
Multidisciplinary
2013English

Proteinase-Activated Receptor 2 and Disease Biomarkers in Cerebrospinal Fluid in Cases With Autopsy-Confirmed Prion Diseases and Other Neurodegenerative Diseases

BMC Neurology
MedicineNeurology
2015English

GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease

Neuron
Neuroscience
2013English

Alzheimer’s Disease Risk Variants Show Association With Cerebrospinal Fluid Amyloid Beta

Neurogenetics
Molecular NeuroscienceGeneticsCellular
2008English

Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients With Alzheimer’s Disease

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy